These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 5616806)

  • 1. [Determination of antibodies to erythrogenic toxin in the passive hemagglutination reaction].
    Kazdobina IS
    Zh Mikrobiol Epidemiol Immunobiol; 1967; 44(3):43-7. PubMed ID: 5616806
    [No Abstract]   [Full Text] [Related]  

  • 2. [The passive hemagglutination test for detection of antibodies to scarlet fever toxin].
    Silich VA; Fiks LI; Cherkasskaia RS
    Zh Mikrobiol Epidemiol Immunobiol; 1972 Aug; 49(8):57-62. PubMed ID: 4673601
    [No Abstract]   [Full Text] [Related]  

  • 3. [Use of hemagglutination reaction in the titration of anti-scarlet fever sera].
    KUSHKO IV
    Zh Mikrobiol Epidemiol Immunobiol; 1960 May; 31():36-9. PubMed ID: 14412942
    [No Abstract]   [Full Text] [Related]  

  • 4. [Antibodies to erythrogenic toxin B in scarlatina patients].
    Silich VA; Fiks LI; Dodonov VN; Sezonova EP
    Zh Mikrobiol Epidemiol Immunobiol; 1975 Mar; 0(3):112-5. PubMed ID: 1092101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of anti group A streptococcal polysaccharide antibodies in human sera by an hemagglutination technique.
    Goldstein I; Caravano R
    Proc Soc Exp Biol Med; 1967 Apr; 124(4):1209-12. PubMed ID: 6024836
    [No Abstract]   [Full Text] [Related]  

  • 6. [Erythrocyte agglutination method in immunological studies in scarlet fever].
    MOLNAR A; NARAI S; FOLDES J
    Gyermekgyogyaszat; 1956; 7(5-6):178-80. PubMed ID: 13345123
    [No Abstract]   [Full Text] [Related]  

  • 7. Quantitative passive hemagglutination: adaptation of the cell migration technique to measurement of antibodies of E. coli.
    Johnson HM; Peeler JT; Hall HE
    J Immunol; 1968 Nov; 101(5):868-75. PubMed ID: 4880294
    [No Abstract]   [Full Text] [Related]  

  • 8. [Erythrogenic toxin. II. The problem of antigenic heterogeneity of scarlet fever toxin. Neutralization tests].
    SCHUH V; JELINEK J
    Cesk Epidemiol Mikrobiol Imunol; 1960 Sep; 9():476-84. PubMed ID: 13748788
    [No Abstract]   [Full Text] [Related]  

  • 9. THE PROPERTIES OF FRAGMENTS OF SKIN-SENSITIZING AND BLOCKING ANTIBODIES AS REVEALED BY THE PRAUSNITZ-KUESTNER, PASSIVE CUTANEOUS ANAPHYLAXIS AND HEMAGGLUTINATION REACTIONS.
    GYENES L; SEHON AH; FREEDMAN SO; OVARY Z
    Int Arch Allergy Appl Immunol; 1964; 24():106-18. PubMed ID: 14128914
    [No Abstract]   [Full Text] [Related]  

  • 10. [The indirect hemagglutination test in pseudotuberculosis (far eastern scarlatina-like fever)].
    Koroliuk AM
    Zh Mikrobiol Epidemiol Immunobiol; 1969 Jan; 46(1):121-5. PubMed ID: 5787560
    [No Abstract]   [Full Text] [Related]  

  • 11. [Purification and crystallization of erythrogenic scarlet fever toxin].
    KUSHKO IV; KONIKOV AP; SHCHEGLOVA AS
    Vopr Med Khim; 1958; 4(1):33-8. PubMed ID: 13557938
    [No Abstract]   [Full Text] [Related]  

  • 12. Preparation of a crystalline erythrogenic scarlet fever toxin.
    KONIKOV AP; KUSHKO IV
    J Hyg Epidemiol Microbiol Immunol; 1957; 1(3):256-61. PubMed ID: 13525727
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies on Culex pipiens molestus in Israel. 3. Immune reactions in laboratory animals to extracts from the mosquito.
    Gold D; Lengy J
    Int Arch Allergy Appl Immunol; 1968; 34(6):571-9. PubMed ID: 4396198
    [No Abstract]   [Full Text] [Related]  

  • 14. [Titration of erythrogenic scarlet fever toxin by means of a quantitative complement fixation].
    TARKHANOVA IO; KONIKOV AP; AKIMOVA VV
    Zh Mikrobiol Epidemiol Immunobiol; 1957 Feb; 28(2):26-32. PubMed ID: 13423804
    [No Abstract]   [Full Text] [Related]  

  • 15. [Characteristics of antitoxic immunity in patients with scarlatina according to passive hemagglutination reaction data].
    Silich VA; Fiks LI; Dodonov VN; Sezonova EP; Novik ZA
    Zh Mikrobiol Epidemiol Immunobiol; 1973 Jul; 50(7):19-23. PubMed ID: 4590982
    [No Abstract]   [Full Text] [Related]  

  • 16. [Antigenic composition of preparations of purified erythrogenic toxin].
    Kazdobina IS; Akimova VV; Burshteĭn VA
    Zh Mikrobiol Epidemiol Immunobiol; 1966 May; 43(5):111-6. PubMed ID: 4975809
    [No Abstract]   [Full Text] [Related]  

  • 17. Studies on the sensitivity of a passive hemagglutination test in the detection of antimeasles antibodies.
    Ghyka GR; Cernescu C; Cajal N
    Rev Roum Virol (1972); 1973; 10(4):295-300. PubMed ID: 4207146
    [No Abstract]   [Full Text] [Related]  

  • 18. [A comparative experimental study of 3 depot preparations of scarlet fever erythrogenic toxin].
    KUSHKO IV; AKIMOVA VV
    Zh Mikrobiol Epidemiol Immunobiol; 1960 Aug; 31():51-4. PubMed ID: 13755376
    [No Abstract]   [Full Text] [Related]  

  • 19. [Mitogenic activity of erythrogenic toxins. I. Type-specific inhibition of the mitogenic activity of erythrogenic toxins by antitoxic antisera from the rabbit (author's transl)].
    Petermann F; Knöll H; Köhler W
    Zentralbl Bakteriol Orig A; 1978 Apr; 240(3):366-79. PubMed ID: 352038
    [No Abstract]   [Full Text] [Related]  

  • 20. Thyroid-stimulating activity in the serum of rabbits immunized with thyroid microsomes.
    Beall GN; Solomon DH
    J Clin Endocrinol Metab; 1968 Apr; 28(4):503-10. PubMed ID: 4868496
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.